234 related articles for article (PubMed ID: 12029439)
21. CD117 and CD34 staining patterns in childhood benign mammary lesions.
Kaçar A; Paker I; Akbiyik F; Arikök AT; Mambet E
Turk Patoloji Derg; 2012; 28(1):31-7. PubMed ID: 22207429
[TBL] [Abstract][Full Text] [Related]
22. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
24. C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
Diallo R; Rody A; Jackisch C; Ting E; Schaefer KL; Kissler S; Karn T; Geddert H; Engels K; Kaufmann M; Gabbert HE; Shroyer KR; Poremba C
Hum Pathol; 2006 Feb; 37(2):205-11. PubMed ID: 16426921
[TBL] [Abstract][Full Text] [Related]
25. [Pathology of premalignant and malignant diseases of the female breast].
Prechtel K
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
30. [Expression of vascular endothelial growth factor in different breast tissues and clinical significance thereof].
Xu WG; Wang G; Liu Y; Zou YH; Song JN; Yang XQ; Wang WY
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):802-4. PubMed ID: 18756980
[TBL] [Abstract][Full Text] [Related]
31. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues.
Asch HL; Eliacin E; Fanning TG; Connolly JL; Bratthauer G; Asch BB
Oncol Res; 1996; 8(6):239-47. PubMed ID: 8895199
[TBL] [Abstract][Full Text] [Related]
32. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer.
Dhar S; Bhargava R; Yunes M; Li B; Goyal J; Naber SP; Wazer DE; Band V
Clin Cancer Res; 2001 Nov; 7(11):3393-8. PubMed ID: 11705853
[TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
34. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
35. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms.
Lien HC; Lu YS; Cheng AL; Chang WC; Jeng YM; Kuo YH; Huang CS; Chang KJ; Yao YT
J Pathol; 2006 Jul; 209(3):317-27. PubMed ID: 16639692
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia].
Song M; Li BL; Mi XY; Gao YX; Song JY
Ai Zheng; 2002 May; 21(5):484-8. PubMed ID: 12452037
[TBL] [Abstract][Full Text] [Related]
39. Inhibitor of differentiation is overexpressed with progression of benign to malignant lesions and related with carcinoembryonic antigen-related cell adhesion molecule 1 distribution in mammary glands.
Liu Q; Yang YM; Zhang QH; Zhang TG; Zhou Q; Zhou CJ
Ann Diagn Pathol; 2011 Feb; 15(1):30-6. PubMed ID: 21106423
[TBL] [Abstract][Full Text] [Related]
40. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.
Andreadis D; Epivatianos A; Poulopoulos A; Nomikos A; Papazoglou G; Antoniades D; Barbatis C
Oral Oncol; 2006 Jan; 42(1):57-65. PubMed ID: 16140564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
